So the FDA does agree that triglyceride-reducing drugs also reduce cardiovascular risks, but only in the over 500 range?
The way you phrased the question could lead to ambiguity. FDA thinks the clinical benefit from lowering triglycerides is clear in the 500+ range and that it remains to be proven in the sub-500 range.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.